Pharmaceutical Preparations companies: boards of directors (SIC 2834)
- Organizations
- 475
- Directors
- 3,605
- Average board size
- 9.4
| Organization | Directors | CEO |
|---|---|---|
| COMPASS Pathways Plc Nasdaq: CMPS · Chesire, United Kingdom | 23 | Kabir Nath |
| Bicycle Therapeutics plc Nasdaq: BCYC · Cambridge, United Kingdom | 21 | Kevin Lee |
| Exicure Inc. Nasdaq: XCUR · Chicago, United States | 20 | Jung Sang Kim |
| Mereo BioPharma Group plc Nasdaq: MREO · London, United Kingdom | 19 | Denise Scots-Knight |
| BioMarin Pharmaceutical Inc. Nasdaq: BMRN · Novato, United States | 18 | Alexander Hardy |
| Jade Biosciences Inc. Nasdaq: JBIO · Waltham, United States | 18 | Tom Frohlich |
| Takeda Pharmaceutical Company Limited NYSE: TAK · Tokyo, Japan | 18 | Christophe Pierre Weber |
| Viatris Inc. Nasdaq: VTRS · Canonsburg, United States | 18 | Michael Goettler |
| Akari Therapeutics plc Nasdaq: AKTX · Tampa, United Kingdom | 17 | Rachelle Suzanne Jacques |
| Johnson & Johnson NYSE: JNJ · New Brunswick, United States | 17 | Joaquin Duato |
| Lexicon Pharmaceuticals Inc. Nasdaq: LXRX · The Woodlands, United States | 17 | Michael Exton |
| Perrigo Company plc NYSE: PRGO · Dublin 2, United States | 17 | Patrick Lockwood-Taylor |
| AbbVie Inc. NYSE: ABBV · North Chicago, United States | 16 | Robert A. Michael |
| Bausch Health Companies Inc. NYSE: BHC · Quebec, Canada | 16 | Thomas Appio |
| Gyre Therapeutics Inc. Nasdaq: GYRE · SAN Diego, United States | 16 | Ying Luo |
| Jazz Pharmaceuticals plc Nasdaq: JAZZ · Dublin, Ireland | 16 | Bruce C. Cozadd |
| Longeveron Inc. Nasdaq: LGVN · Miami, United States | 16 | Mohamed Wa'el Ahmed Hashad |
| Lunai Bioworks Inc. Nasdaq: LNAI · Suite 906 LOS Angeles, United States | 16 | David Hershel Weinstein |
| Zymeworks Inc. Nasdaq: ZYME · Middletown, United States | 16 | Kenneth Galbraith |
| Alnylam Pharmaceuticals Inc. Nasdaq: ALNY · Cambridge, United States | 15 | Yvonne Greenstreet |
| Aurinia Pharmaceuticals Inc Nasdaq: AUPH · Edmonton, Canada | 15 | Peter Greenleaf |
| BeOne Medicines Ltd. Nasdaq: ONC · Basel, Cayman Islands | 15 | John Oyler |
| BridgeBio Pharma Inc. Nasdaq: BBIO · Palo Alto, United States | 15 | Neil Kumar |
| Crescent Biopharma Inc. Nasdaq: CBIO · Waltham, United States | 15 | Joshua T. Brumm |
| Cue Biopharma Inc. Nasdaq: CUE · Boston, United States | 15 | Shao-Lee Lin |
| Damora Therapeutics Inc. Nasdaq: DMRA · Waltham, Denmark | 15 | Hans T. Schambye |
| Elanco Animal Health Incorporated NYSE: ELAN · Indianapolis, United States | 15 | Jeffrey N. Simmons |
| Eli Lilly and Company NYSE: LLY · Indianapolis, United States | 15 | David A. Ricks |
| Faeth Therapeutics Inc. Nasdaq: FTH · Austin, United States | 15 | John Celebi |
| Lifecore Biomedical Inc. Nasdaq: LFCR · Chaska, United States | 15 | Paul Josephs |
| Oruka Therapeutics Inc. Nasdaq: ORKA · Menlo Park, United States | 15 | Lawrence Otto Klein |
| Palvella Therapeutics Inc. Nasdaq: PVLA · Wayne, United States | 15 | Wes Kaupinen |
| PTC Therapeutics Inc. Nasdaq: PTCT · Warren, United States | 15 | Stuart Walter Peltz |
| Regeneron Pharmaceuticals Inc. Nasdaq: REGN · Tarrytown, United States | 15 | Leonard S. Schleifer |
| United Therapeutics Corporation Nasdaq: UTHR · Silver Spring, United States | 15 | Martine A. Rothblatt |
| Vertex Pharmaceuticals Incorporated Nasdaq: VRTX · Boston, United States | 15 | Reshma Kewalramani |
| Zoetis Inc. NYSE: ZTS · Parsippany, United States | 15 | Kristin C. Peck |
| Abbott Laboratories NYSE: ABT · Abbott Park, United States | 14 | Robert B. Ford |
| Alkermes plc Nasdaq: ALKS · Dublin 4, Ireland | 14 | Richard F. Pops |
| Arbutus Biopharma Corporation Nasdaq: ABUS · Warminster, Canada | 14 | Lindsay Androski |
| Bicara Therapeutics Inc. Nasdaq: BCAX · Boston, United States | 14 | Claire Mazumdar |
| Dianthus Therapeutics Inc. Nasdaq: DNTH · New York, United States | 14 | Marino Garcia |
| Enliven Therapeutics Inc. Nasdaq: ELVN · Burlingame, United States | 14 | Richard A. Fair |
| Indaptus Therapeutics Inc. Nasdaq: INDP · New York, United States | 14 | Jeffrey A. Meckler |
| KALA BIO Inc. Nasdaq: KALA · Arlington, United States | 14 | Avraham Minkowitz |
| Korsana Biosciences Inc. Nasdaq: KRSA · Waltham, United States | 14 | Peter M. Hecht |
| Lite Strategy Inc. Nasdaq: LITS · SAN Diego, United States | 14 | David M. Urso |
| Merck & Company Inc. NYSE: MRK · Rahway, United States | 14 | Robert M. Davis |
| Mineralys Therapeutics Inc. Nasdaq: MLYS · Radnor, United States | 14 | Jon Congleton |
| OnKure Therapeutics Inc. Nasdaq: OKUR · Boulder, United States | 14 | Nicholas A. Saccomano |
Organizations whose headquarters, sector or industry code is on file and that have at least one current director. Sectors not on file are derived from the industry code (an approximate match to GICS). Board sizes count every current seat on record; see where our data comes from.